Anna Mowry, CFO and Treasurer at Nautilus Biotechnology, Inc. (NAUT), bought 15,000 shares at $0.77 ($12K) on 2025-05-29, disclosed to the SEC on 2025-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NAUT | BUY | 2021-11-24 | $69K | — | Filing → |
| NAUT | BUY | 2021-08-16 | $135K | — | Filing → |